DOCSLIB.ORG

SPORTS MEDICINE Recent Titles in Health and Medical Issues Today

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SPORTS MEDICINE Recent Titles in Health and Medical Issues Today SPORTS MEDICINE Recent Titles in Health and Medical Issues Today Obesity Evelyn B. Kelly Stem Cells Evelyn B. Kelly Organ Transplantation David Petechuk Alternative Medicine Christine A. Larson Gene Therapy Evelyn B. Kelly SPORTS MEDICINE Jennifer L. Minigh Health and Medical Issues Today GREENWOOD PRESS Westport, Connecticut ● London Library of Congress Cataloging-in-Publication Data Minigh, Jennifer L., 1971- Sports medicine / Jennifer L. Minigh. p. ; cm. — (Health and medical issues today, ISSN 1558-7592) Includes bibliographical references and index. ISBN-13: 978-0-313-33894-6 (alk. paper) ISBN-10: 0-313-33894-9 (alk. paper) 1. Sports medicine—Popular works. I. Title. II. Series. [DNLM: 1. Sports Medicine—Popular Works. 2. Athletic Injuries—Popular Works. 3. Doping in Sports—Popular Works. QT 261 M665s 2007] RC1210.M495 2007 617.1'027—dc22 2007021471 British Library Cataloguing in Publication Data is available. Copyright © 2007 by Jennifer L. Minigh All rights reserved. No portion of this book may be reproduced, by any process or technique, without the express written consent of the publisher. Library of Congress Catalog Card Number: 2007021471 ISBN-13: 978–0–313–33894–6 ISBN-10: 0–313–33894–9 ISSN: 1558–7592 First published in 2007 Greenwood Press, 88 Post Road West, Westport, CT 06881 An imprint of Greenwood Publishing Group, Inc. www.greenwood.com Printed in the United States of America The paper used in this book complies with the Permanent Paper Standard issued by the National Information Standards Organization (Z39.48–1984). 10987654321 CONTENTS Series Foreword ix Preface xi Acknowledgments xv Section One Overview 1The Field of Sports Medicine 3 Careers in Sports Medicine 4 Show Me the Money 9 Office versus Field Care 12 Managed Care 15 2 History of Sports Medicine 19 Ancient History 19 Jump to the 1900s 20 The Advent of Sports Medicine 20 Scientific Advancements 21 Onset of Sports Law 22 Confidentiality and Defamation 27 3 Common Sports Injuries 31 Injuries in Children 32 Injuries in Adults 33 vi CONTENTS Injuries in Disabled Athletes 33 Types of Injuries 33 Location of Injuries 36 4The Impact of a Sports Injury—Who Does It Hurt? 47 Athletes 47 Families 50 Team and Coaches 50 Insurance Companies 51 Physicians and Healthcare Professionals 52 Media and Fans 53 Society as a Whole 54 5Doping 57 Doping Strategies 57 Doping Substances 58 6The Future of Sports Science 61 Tissue Engineering 62 Gene Therapy 62 Designer Drugs 63 Bionics 64 Section Two Controversies and Issues 7 Issue: Informed Consent 73 Informed Consent in Sports Medicine 74 Implied Consent 76 Consent in Research 76 Playing Against Medical Advice 77 Coercion 78 Cases Involving Informed Consent 79 What Does This Mean for Team Physicians? 80 8 Issue: Who Has the Right to Play? 83 Preparticipation Examinations 83 Disabled/Handicapped Athletes 88 Athletes with Predisposition to Injury 93 AIDS and Hepatitis 97 Transgendered Athletes 100 CONTENTS vii 9 Issue: Are Sports Too Aggressive and Violent? 103 Science of Aggression 105 Game Aggression and Violence 106 Spectator Aggression 108 Aggression Off the Field 109 Roid Rage 109 10 Issue: Performance Enhancement 113 Anabolic Steroids 113 Gene Doping 115 Blood Doping 116 Growth Hormone 117 Stimulants 117 Painkillers 119 Beta-adrenergic Agents 120 Regulation and Testing of Substances 121 BALCO Investigation 123 Surgery 124 11 Issue: Who Is Liable? 127 Standard of Care 127 Malpractice and Negligence 129 Return to Play 130 Liability 132 Rehabilitation 134 12 Issue: Who Has the Right to Know and to Tell 137 Confidentiality 137 HIPAA 138 Defamation 139 Premature Release of Doping Results 139 13 Issue: Medical Advertising 143 Sponsorship 143 Selflessness 144 Untruthful Advertising and False Claims 145 Exaggerated Claims 146 14 Issue: Nutrition 149 What to Eat 149 Supplements 152 viii CONTENTS Sport Drinks 154 When to Eat 155 Safety and Regulation 156 15 Issue: How Much Is Too Much? 159 How Young Is Too Young? 159 No Pain, No Gain 162 Designer Athletes 165 Steroids 165 Evidence-Based Medicine and Innovative Therapies 166 Section Three References and Resources A Annotated Primary Source Documents 171 BTimeline of Sports Medicine Issues 237 C Glossary 241 D Further Reading 243 Index 249 SERIES FOREWORD Every day, the public is bombarded with information on developments in medicine and health care. Whether it is on the latest techniques in treat- ments or research, or on concerns over public health threats, this informa- tion directly impacts the lives of people more than almost any other issue. Although there are many sources for understanding these topics—from Web sites and blogs to newspapers and magazines—students and ordi- nary citizens often need one resource that makes sense of the complex health and medical issues affecting their daily lives. The Health and Medical Issues Today series provides just such a one- stop resource for obtaining a solid overview of the most controversial areas of healthcare today. Each volume addresses one topic and provides a balanced summary of what is known. These volumes provide an excellent first step for students and lay people interested in understanding how healthcare works in our society today. Each volume is broken into several sections to provide readers and researchers with easy access to the information they need: • Section I provides overview chapters on background information— including chapters on such areas as the historical, scientific, medical, social, and legal issues involved—that a citizen needs to intelligently understand the topic. • Section II provides capsule examinations of the most heated con- temporary issues and debates, and analyzes in a balanced manner the viewpoints held by various advocates in the debates. x SERIES FOREWORD • Section III provides a selection of reference material, including anno- tated primary source documents, a timeline of important events, and an annotated bibliography of useful print and electronic resources that serve as the best next step in learning about the topic at hand. The Health and Medical Issues Today series strives to provide readers with all the information needed to begin making sense of some of the most important debates going on in the world today. The series will include volumes on such topics as stem-cell research, obesity, gene ther- apy, alternative medicine, organ transplantation, mental health, and more. PREFACE This title describes the turmoil seen in sports medicine when balancing scientific, legal, and ethical issues. In this book, sports medicine is defined not only by the customary defi- nition, but also by the issues surrounding the industry. Readers will gain a true appreciation for the complexity and intricacies of these issues that weave the tangled web of sports medicine. In the end, readers will under- stand the background and history of sports medicine, possess both sides of related scientific, legal, and ethical issues, and have a new respect for everyone involved in the field. Developed according to the guidelines of the Greenwood Press Health and Medical Issues Today series, this book was written as a reference for students and others who want to know more about sports medicine. As such, this book is different from other books on sports medicine in that it seeks to present both the science and the issues surrounding this field. Because a position is not taken on the issues, the information is balanced and thus ideal for those individuals who want an unbiased account. Section One (Chapters 1–6) lays the groundwork for sports medicine and the science, legality, and ethics involved. Section Two (Chapters 7–15) explains the various issues in sports medicine. Section Three lists the references and resources for further information. Chapter 1, “The Field of Sports Medicine,” defines sports medicine and details the careers, responsibilities, and working environment of a sports medicine professional. xii PREFACE Chapter 2, “History of Sports Medicine,” describes the historical evolu- tion of the sports medicine field, including the emergence of related scien- tific, legal, and ethical issues. Chapter 3, “Common Sports Injuries,” describes many of the most frequently occuring sports injuries and the sports in which these injuries occur. In addition, the often overlooked issue of injuries to disabled athletes is covered. Chapter 4, “The Impact of a Sports Injury—Who Does It Hurt?,” emphasizes the shock wave following the injury, not only for the injured athlete but also for the athlete’s family, team, and competitors. Issues involving insurance, medical care and care providers, the news media, and sports equipment are also considered in the light of sports injuries. Chapter 5, “Doping,” looks at the history and issues surrounding the use of performance enhancing substances. The chapter also provides an overview of doping strategies. Chapter 6, “The Future of Sports Science,” takes a look at what we will see in this field in the years ahead. Among the areas explored are injury prevention, gene therapy, new drugs, the frontiers of bionics, and the impact of science on sports medicine law. Chapter 7 tackles the issues of informed consent as it applies to sports medicine. Informed consent for injured athletes is an area where often conflicting interests are involved in decisions. This chapter reviews this complex aspect of athletics. Chapter 8 describes the issues involved with the right to play sports. It asks the question, “Who has the right to play?” Among the issues covered are physical fitness, the return to play following injury, and the many impacts of barring athletes from play. Chapter 9 asks, “Are sports too aggressive and violent?” The issues of aggression and violence are covered along with related topics as body chemistry, medications and drugs, and fan involvement. Chapter 10 covers the battles over performance enhance in sports. The topics covered include not only the widely known performance enhancing drugs, but also such topics as gene doping, blood doping, and the role of drug companies in this area.
Load more

Recommended publications
  • Dr. Lewis Yocum J U L Y 2 0 1 3
    PBATS.COM S P E C I A L P O I N T S O F TALES OF THE TAPE INTEREST: DR. LEWIS YOCUM J U L Y 2 0 1 3 DR. LEWIS YOCUM— LOS ANGLES ANGELS OF DR. LEWIS YOCUM ANAHEIM DR. LEWIS YOCUM— “He was a dear friend and mentor. We both FAMILY and started together in 1978 and had been together for 36 FRIENDS years. One of our best moments was the 2002 World th DR. LEWIS Championship during our 25 year together. YOCUM— PBATS PRES- Dr. Yocum was a family man, humble, a gentleman, IDENTS witty, had a dry sense of humor, dedicated, honest, sin- DR. LEWIS cere, grateful and always looked after the best interests YOCUM— of his patients no matter who they were. PBATS HALL OF FAME We were both “foodies” and loved chasing great restau- rants, food, cigars. When we had dinner together (and we had many) we almost always talked about our fami- lies, friends, food, and our travels. INSIDE THIS ISSUE: Dr. Yocum always had time for everyone from the owner of the team, a summer intern, a bat boy, or another physician. ADAM NEVALA 2 DON YOCUM 3 He was a brilliant surgeon but almost always preferred to take the con- servative route with therapy, prehab, rehab, and exercise programs. SUE O’DRISCOLL 3 He was the best teacher I ever had and was always willing to share his PAST PBATS PRESI- 4-6 DENTS knowledge, wisdom, and expertise. RICHIE BANCELLS 5 He was always very proud of the educational values and opportunities that PBATS made available and also what PBATS stood for.
    [Show full text]
  • Frank Jobe Developed Elbow Reconstruction Surgery to Save Careers of Baseball Players
    OBITUARIES Frank Jobe Developed elbow reconstruction surgery to save careers of baseball players Frank Jobe (b 1925; q Loma Linda University After John’s surgery in 1974, Jobe patiently 1956), had been admitted to hospital with an waited to see the result before performing the undisclosed illness and died on 6 March 2014. procedure on others. “I knew I could transfer a tendon,” he later said. “But I didn’t know Frank Jobe, team doctor for the Los Angeles whether or not it would revascularise and Dodgers baseball club, was watching his team be strong like a ligament under stress.” Only play in July 1974 when something strange after John’s successful return to baseball did happened. The Dodger’s star pitcher, Tommy Jobe perform the procedure on others. He John, threw the baseball toward the batter published key papers on the method in 1986 standing at the home plate, but the throw was and 1992,1 2 and eventually performed the weak. John would later say that as he threw he surgery hundreds of times and trained others “felt a kind of nothingness,” as if his arm were to do it. not there. And then he heard a pop from inside The procedure, medically termed ulnar his arm. collateral ligament reconstruction but John was pulled from the game and was commonly called Tommy John surgery in the diagnosed with a ruptured ulnar collateral US, is now routine. Among pitchers playing ligament (UCL) in the medial elbow. This was professionally in 2012, about 14% had not an uncommon injury for a pitcher, but it undergone the procedure.
    [Show full text]
  • Sports Inc__Volume 7 Issue 1.Pdf (6.555Mb)
    Cornell University’s ILR School Sports, Inc. A Tension Between the NBA and the Olympics Pages 7 - 11 ILR Sports Business Society - Fall 2014 - Volume VII, Issue 1 MAGAZINE STAFF EXECUTIVE BOARD Editor-in-Chief Jesse Sherman ‘15 Advisor Kevin Harris Layout Editor Lauren Mahaney ‘16 President Alex Smith ‘15 Content Editor Gabe Cassillo ‘15 VP of Magazine Jesse Sherman ‘15 Writer /Editor Andrew Distler ‘15 VP of Finance Kevin Cole ‘15 Writer/Editor Evan Lefkovitz ‘16 VP of Radio Matt Hakimian ‘16 Writer/Editor Jason Lefkovitz ‘16 VP of Blog Stephen Rosen ‘15 Writer Taylor Kosakoff ‘16 VP of Events Dan Cappetta ‘15 Writer Damian O’Sullivan ‘17 VP of Marketing Lauren Mahaney‘16 Writer Karthik Sekharan ‘17 VP of Alumni Affairs Sarah Gilman ‘16 Writer Magic Peng ‘18 Director of Career Services Taylor Kosakoff ‘16 Director of Operations Mike Wolkon ‘16 The ILR Sports Business Society, an independent student organization located at Cornell University, produced and is responsible for the content of this publication. This publication was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, Cornell University or its designated representatives. 2 Sports, Inc. The Inc.’s INK Volume VII, Issue 1: Fall 2014 A Changing Landscape: Today’s Sports Issues Also Featuring Why They Call Him “Money” by Page 11 Karthik Sekharan Page 5 “Socialism” Defeats “Capitalism” on the Pitch The Olympics as a Legal by Magic Peng Steroid: How Participation Enhances NBA Player Performance by Jason Lefkovitz Page 7 Page 20 A New Dead Ball Era? How Tommy John Surgery The Effects of Declining Affects Baseball by Damian Offense in Baseball by O’Sullivan Andrew Distler Page 13 A Case Study of Apparel Sponsorship in Sports by Evan Lefkovitz Page 23 Page17 Business Sponsors and the Public Press for Change by Taylor Kosakoff Fall 2014 3 The President’s Greeting: Alex Smith ‘15 First, thank you for taking the time to read the ILR Cornell Sports Business Society Magazine.
    [Show full text]
  • Elective Performance Enhancement Surgery for Athletes: Should It Be Resisted?
    Acta Univ. Palacki. Olomuc., Gymn. 2006, vol. 36, no. 2 39 ELECTIVE PERFORMANCE ENHANCEMENT SURGERY FOR ATHLETES: SHOULD IT BE RESISTED? Mark Hamilton Ashland University, Ashland, USA Submitted in September, 2005 The following article describes some surgeries used to enhance athletic performance along with discussion of possible ones that could be used in the upcoming years for this purpose. Elective eye surgery is used by numerous athletes in sports where sight is an essential aspect of success. This raises the ethical question of whether it is morally acceptable to perform enhancement surgery for the purpose of developing capabilities that are superior to normal, such as 20/10 vision. Criteria to determine the morality of these actions is necessary, especially when the surgery is optional and is motivated not by therapeutic needs but to enhance performance and to create an ability above and beyond the norm. It is one thing to have corrective surgery for convenience’s sake or to slow down deterioration, but it is quite another to do it to create superior vision, such as 20/10. With the acceptance of this rather benign eye surgery and due to the advances in minimally invasive surgical tech- niques, the crackdown on steroid usage, and the growing financial incentives for athletes, it is only a matter of time before this evolves into athletes having elective surgeries to become bigger, stronger, or faster. Elective surgery will expand in its usage to enhance performance. This raises a plethora of moral issues, therefore there must be serious pursuit of criteria to evaluate the morality of this type of elective surgery and encouragement of athletic institutions to be proactive in policy making.
    [Show full text]
  • Type 1 Diabetes
    Type 1 Diabetes Clinical Management of the Athlete Ian Gallen Editor Type 1 Diabetes Clinical Management of the Athlete Editor Ian Gallen Diabetes Centre Wycombe Hospital High Wycombe UK ISBN 978-0-85729-753-2 e-ISBN 978-0-85729-754-9 DOI 10.1007/978-0-85729-754-9 Springer London Dordrecht Heidelberg New York British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library Library of Congress Control Number: 2012934821 © Springer-Verlag London Limited 2012 Apart from any fair dealing for the purposes of research or private study, or criticism or review, as permitted under the Copyright, Designs and Patents Act 1988, this publication may only be reproduced, stored or transmitted, in any form or by any means, with the prior permission in writing of the publishers, or in the case of reprographic reproduction in accordance with the terms of licenses issued by the Copyright Licensing Agency. Enquiries concerning reproduction outside those terms should be sent to the publishers. The use of registered names, trademarks, etc., in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant laws and regulations and therefore free for general use. Product liability: The publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) This book is dedicated to my parents Louis and Barbara for their lifelong love, encouragement and support, to my wife Susan for our happy life together and to our children Robert and Hannah who make my life meaningful.
    [Show full text]
  • Copyright by Daniel Lukas Rosenke 2020 the Dissertation Committee for Daniel Lukas Rosenke Certifies That This Is the Approved Version of the Following Dissertation
    Copyright by Daniel Lukas Rosenke 2020 The Dissertation Committee for Daniel Lukas Rosenke Certifies that this is the approved version of the following Dissertation: Supply and Enhance: Tracing the Doping Supply Chain in the 1980s Committee: Janice S. Todd, Supervisor Thomas M. Hunt Tolga Ozyurtcu John Hoberman Ian Ritchie Supply and Enhance: Tracing the Doping Supply Chain in the 1980s by Daniel Lukas Rosenke Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfilment of the Requirements for the degree of Doctor of Philosophy The University of Texas at Austin August 2020 Dedication To my mother, the strongest woman I know To Adam: my brother, best friend, and forever my partner in crime Acknowledgements This project may never have come to fruition without the influence of father, Scott Rosenke. In my young and more impressionable years, he molded me into a man of confidence and conviction, and inspired in me the unwavering self-belief to pursue my dreams, no matter how far-fetched. Perhaps most significantly, I credit him with first introducing me to the subject matter I discuss in this volume, and piquing my interest in the surreptitious drug culture in Olympic and professional sports. Sometime in our mid-teens, I recall my brother Adam – my handsome identical twin – and I seated on the couch with Dad watching Lance Armstrong’s second Tour de France victory. At the time many believed the brash cycling maverick from Plano, Texas, a folk hero among cancer survivors worldwide, was a manna from heaven, sent to restore faith in the sport after a widely-reported scandal at the Tour two years earlier.
    [Show full text]
  • Note Balancing the Justices in Anti
    Note Balancing the Justices in Anti-Doping Law: The Need to Ensure Fair Athletic Competition Through Effective Anti-Doping Programs vs. the Protection of Rights of Accused Athletes Ryan Connolly∗ Introduction................................................................................................... 42 I. Structure of the Current International System .......................................... 43 A. Court of Arbitration for Sport........................................................... 43 B. U.S. Anti-Doping Agency ................................................................ 45 II. Unique Issues Contributing to Anti-Doping’s Jurisprudential Community ............................................................................................ 46 A. Scientific Limitations........................................................................ 46 B. Pharmaceutical Innovations.............................................................. 49 C. Dietary Supplements......................................................................... 50 D. Designer Steroids.............................................................................. 52 E. Effect on Anti-Doping Law.............................................................. 54 III. Anti-Doping Jurisprudence ..................................................................... 54 A. Procedural Issues.............................................................................. 54 ∗ The author of this essay has been the Business Manager and Consultant for the UCLA Olympic Analytical
    [Show full text]
  • The Tim Ferriss Show Transcripts Episode 143: Patrick Arnold Show Notes and Links at Tim.Blog/Podcast
    The Tim Ferriss Show Transcripts Episode 143: Patrick Arnold Show notes and links at tim.blog/podcast Tim Ferriss: Greetings, my little Mogwai. This is Tim Ferriss, and I'm going to redo a legal disclaimer for this episode. I don't do many of these, but at the behest of my ever-so-competent legal counsel, allow me to read the following. I am not recommending, endorsing or supporting any of the substances or compounds discussed or described in this interview, particularly, when this applies to illegal, illicit or dangerous compounds or substances. I am interviewing Patrick, furthermore, as a journalist seeking additional information regarding matters of public interest and concern. You should also notice that we have removed a number of names of different folks to protect the innocent, guilty or otherwise. With all of that said, since I've covered my little white ass, please enjoy. [Intro] Hello you freaks out there, and aren't we all freaks at the end of the day? This is Tim Ferriss, and welcome to another episode of The Tim Ferriss Show. If you liked my episode with Dom D’Agostino, the incredible scientist who fasted six, seven days, whatever it was, dead-lifted 500 pounds for ten reps, and continues to do amazing work for the Department of Defense with exogenous ketones, etc., etc., you might love this one. So here we go. Patrick Arnold is widely considered the father of prohormones. He's also an organic chemist known for introducing androstenedione – remember Mark McGuire – 1 androstenediol, marketed as 1AD, and methylhexanamine, if I'm getting that correct, into the dietary supplement market.
    [Show full text]
  • A Behavioral Law and Economics Approach to Legal Regulation of Doping in Sports Shayna M
    Marquette Sports Law Review Volume 19 Article 7 Issue 1 Fall Are We All Dopes? A Behavioral Law and Economics Approach to Legal Regulation of Doping in Sports Shayna M. Sigman Follow this and additional works at: http://scholarship.law.marquette.edu/sportslaw Part of the Entertainment and Sports Law Commons Repository Citation Shayna M. Sigman, Are We All Dopes? A Behavioral Law and Economics Approach to Legal Regulation of Doping in Sports, 19 Marq. Sports L. Rev. 125 (2008) Available at: http://scholarship.law.marquette.edu/sportslaw/vol19/iss1/7 This Symposium is brought to you for free and open access by the Journals at Marquette Law Scholarly Commons. For more information, please contact [email protected]. ARE WE ALL DOPES? A BEHAVIORAL LAW & ECONOMICS APPROACH TO LEGAL REGULATION OF DOPING IN SPORTS SHAYNA M. SIGMAN* INTRODUCTION You should care about the prevalence of performance-enhancing drugs (PEDs) and doping methods currently being used and abused within elite sports. You should care, not because teenagers and youth are harmed by this, even though they most likely are. 1 You should care, not because elite athletes or those attempting to become elite athletes are harmed by this, even though they most likely are. 2 Whether you are a recreational athlete or a couch potato, whether you are a serious sports fan, a casual fan, or not a fan at all, you should care about the fact that it is highly likely that you have been harmed by doping in sports. Associate Professor of Law, Jacob D. Fuchsberg Touro Law Center.
    [Show full text]
  • Der Testosteron-Almanach
    DER TESTOSTERON-ALMANACH Prof. Dr. Peter Shultz, Facharzt für Andrologie an der Washington University Deutsche Übersetzung und deutsches Vertriebsrecht Powerchamp Ltd., UK / www.muskelnet-xtreme.com Inhaltsverzeichnis 3 ... Allgemeine Informationen über Testosteron 24 ... Testosteron Enantat 26 ... Testosteron Propionat 29 ... Testosteron Phenylpropionat 31 ... Testosteron Cypionat 33 ... Testosteron Suspension 36 ... Testosteron Mischpräparate 38 ... Testosteron Butyrat 39 ... Testosteron Heptylat 40 ... Testosteron Cyclohexylpropionat 41 ... Testosteron Undecanoat (Injektion) 42 ... Testosteron Buciclat (Injektion) 43 ... Testosteron Undecanoat (Oral) 47 ... Methyltestosteron 49 ... Testosteron Buccaltabletten 50 ... Testosteron Zäpfchen 51 ... Testosteron Pellets 52 ... Testoteron Gel 54 ... Testosteronpflaster 55 ... Dihydrotestosteron 57 ... Mestanolon 58 ... Mesterolon 61 ... 4-Hydroxytestosteron 63 ... 1- Testosteron 65 ... Methyl-1-Testosteron (M1T) 66 ... Testosteron Nicotinat 67 ... Dimethyltestosteron (Bolasteron) 70 ... Testosteron Decanoat 71 ... Testosteron Phenylacetat 72 ... Testosteron Hexahydrobenzoat 73 ... Testosteron Isobutyrat 74 ... Testosteron-Östradiol-Kombinationspräparate 76 ... Testosteron-Nandrolon-Methylandrostendiol-Kombinationspräparate 78 ... Desoxymethyltestosteron (Madol) 2 Der Testosteron-Almanach © www.muskelnet-xtreme.com - Shop für Fatburner und Muskelaufbau-Supplements Allgemeine Informationen über Testosteron Chemische Struktur 17b-hydroxy-4- androsten-3-one Summenformel C19H28O2 Molekulargewicht
    [Show full text]
  • Frontiers of Chemistry2.Pptx
    Designer Drugs: From Performance Enhancers to Legal Highs OH CH3 CH3 H H H O Testosterone Eric E. Buck Frontiers of Chemistry June 30, 2012 Eric Buck @ Wipf Group Page 1 of 49 7/7/2012 Outline • Doping in Major League Baseball • Anabolic Steroids • An Overview of Cannabinoids • A Frontier of Legal Highs Eric Buck @ Wipf Group Page 2 of 49 7/7/2012 5 Classifications of Controlled Substances Schedule I Controlled Substances Substances in this schedule have a high potential for abuse, have no currently accepted medical use in treatment in the United States, and there is a lack of accepted safety for use of the drug or other substance under medical supervision. H3C O O H O H O N O H N CH3 O H3C O CH3 OH MDMA Heroin H Ecstasy H H C 3 O CH3 CH3 THC Eric Buck @ Wipf Group Page 3 of 49 7/7/2012 5 Classifications of Controlled Substances Schedule II Controlled Substances Substances in this schedule have a high potential for abuse which may lead to severe psychological or physical dependence. There is currently accepted medical us with severe restrictions. HO H3C NMe O 2 NH2 O H H3C H N Ph Ph CH3 CH3 HO morphine methadone amphetamine Adderall, Dexedrine, Dextrostat, Desoxyn Eric Buck @ Wipf Group Page 4 of 49 7/7/2012 5 Classifications of Controlled Substances Schedule III Controlled Substances Substances in this schedule have a potential for abuse less than substances in schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence.
    [Show full text]
  • The $90,000,000 Man: Bonds, BALCO and Baseball
    The $90,000,000 Man: Bonds, BALCO and Baseball By Evelyn Milias Senior Division Historical Paper Word Count: 2,496 In 1998, Barry Bonds was in his fifth season with the San Francisco Giants, and his twelfth season in Major League Baseball. It was a record-breaking season for Bonds: he hit his 400th home run and became the only player ever to have 400 home runs and 400 stolen bases, and received his eighth Golden Glove award.1 Despite Bonds’ accomplishments, he was overshadowed that season by the home run slugfest between the Chicago Cubs’ Sammy Sosa and Mark McGwire of the Oakland A’s. McGwire finished the 1998 season with a new record 70 home runs.2 Bonds, feeling jealous,3 broke McGwire’s record in 2001 with 73 single-season home runs. In August 2007, Bonds hit his 756th home run in his home ballpark, breaking the all-time home run record previously held by Hank Aaron.4 His accomplishments were a triumph for him as a player, and for all of the MLB. However, allegations of steroid use tainted Bonds’ records; his record-breaking ball was purchased at auction then sent to the Baseball Hall of Fame with an asterisk on it,5 representing the lingering questions surrounding the underlying reasons for Bonds’ athletic prowess, as well as those of many other elite athletes. Ultimately, Bonds’ triumphant breaking of a long-standing home run record, as well as a season home run record, were overshadowed by the tragedy of steroid use allegations and criminal investigations. One organization, Bay Area Laboratory Co-operative (“BALCO”), connected Bonds and many of these other athletes.
    [Show full text]